Innovative Medicines Initiative

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:Partnerships
gptkbp:addresses rare diseases
chronic diseases
infectious diseases
gptkbp:aims_to foster innovation
enhance competitiveness
improve health
reduce time to market for new medicines
accelerate patient access to therapies
gptkbp:collaborates_with gptkb:pharmaceuticals
gptkb:European_Commission
gptkbp:contributes_to European health research
gptkbp:develops new methodologies
gptkbp:encourages collaborative research
patient involvement
gptkbp:enhances drug development processes
gptkbp:facilitates data sharing
gptkbp:focuses_on research and development
gptkbp:founded gptkb:2008
gptkbp:funding 1.7 billion euros
gptkbp:has_impact_on public health
healthcare systems
gptkbp:has_partnerships_with academic institutions
regulatory bodies
biotech companies
patient organizations
gptkbp:has_project gptkb:IMI2
IMI1
gptkbp:headquartered_in gptkb:Brussels
https://www.w3.org/2000/01/rdf-schema#label Innovative Medicines Initiative
gptkbp:involves stakeholders
gptkbp:is_evaluated_by independent experts
gptkbp:is_involved_in clinical trials
personalized medicine
big data analytics
biomedical research
vaccine development
digital health solutions
health technology assessment
healthcare innovation
regulatory science
gptkbp:is_part_of gptkb:Horizon_2020
EU health initiatives
gptkbp:is_recognized_by gptkb:European_Union
healthcare stakeholders
gptkbp:is_supported_by gptkb:European_Medicines_Agency
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
research organizations
various universities
gptkbp:operates_in gptkb:Europe
gptkbp:promotes public-private collaboration
gptkbp:provides funding opportunities
gptkbp:supports innovative healthcare solutions
gptkbp:bfsParent gptkb:Blueprint_Medicines
gptkb:Vertex_Pharmaceuticals
gptkbp:bfsLayer 4